Skip to main content
Top
Published in: Cancer Causes & Control 6/2006

01-08-2006 | Original Paper

Varying Levels of Family History of Breast Cancer in Relation to Mammographic Breast Density (United States)

Authors: Anthony B. Crest, Erin J. Aiello, Melissa L. Anderson, Diana S. M. Buist

Published in: Cancer Causes & Control | Issue 6/2006

Login to get access

Abstract

Objective

We examined the relationship between breast cancer family history and mammographic breast density.

Methods

Participants included 35,019 postmenopausal women aged ≥40 years enrolled in a population-based mammography screening program. We collected data on the number and type of 1st and 2nd degree female relatives with a history of breast cancer and their ages at diagnosis. We used the Breast Imaging Reporting and Data System™ breast density categories to identify women with fatty (1 = almost entirely fatty or 2 = scattered fibroglandular tissue) and dense (3 = heterogeneously dense or 4 = extremely dense) breasts. We used logistic regression to calculate odds ratios (OR) and 95% confidence intervals for dense (N = 18,111) compared to fatty breasts (N = 16,908).

Results

The odds of having dense breasts were 17% greater for women with affected 1st degree relatives than women with no family history. The odds increased with more affected 1st degree relatives [≥3 vs. none (OR = 1.46; 1.05–2.01)] and among women with ≥1 affected 1st degree relative diagnosed <50 years (OR = 1.22; 1.10–1.34).

Conclusions

Having a family history of breast cancer was more strongly associated with mammographic breast density when the affected relatives were more genetically similar. There may be common, yet undiscovered, genetic elements that affect breast cancer and mammographic breast density.
Literature
1.
go back to reference Kerlikowske, K, Grady, D, Barclay, J, Sickles, EA, Ernster, V 1996Effect of age, breast density, and family history on the sensitivity of first screening mammographyJAMA2763338PubMedCrossRef Kerlikowske, K, Grady, D, Barclay, J, Sickles, EA, Ernster, V 1996Effect of age, breast density, and family history on the sensitivity of first screening mammographyJAMA2763338PubMedCrossRef
2.
go back to reference Mandelson, MT, Oestreicher, N, Porter, PL, White, D, Finder, CA, Taplin, SH, et al. 2000Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancersJ Natl Cancer Inst9210811087PubMedCrossRef Mandelson, MT, Oestreicher, N, Porter, PL, White, D, Finder, CA, Taplin, SH,  et al. 2000Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancersJ Natl Cancer Inst9210811087PubMedCrossRef
3.
go back to reference Boyd, NF, Jensen, HM, Cooke, G, Han, HL, Lockwood, GA, Miller, AB 2000Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening StudyEur J Cancer Prev91524PubMedCrossRef Boyd, NF, Jensen, HM, Cooke, G, Han, HL, Lockwood, GA, Miller, AB 2000Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening StudyEur J Cancer Prev91524PubMedCrossRef
4.
go back to reference Guo, YP, Martin, LJ, Hanna, W, Banerjee, D, Miller, N, Fishell, E, et al. 2001Growth factors and stromal matrix proteins associated with mammographic densitiesCancer Epidemiol Biomarkers Prev10243248PubMed Guo, YP, Martin, LJ, Hanna, W, Banerjee, D, Miller, N, Fishell, E,  et al. 2001Growth factors and stromal matrix proteins associated with mammographic densitiesCancer Epidemiol Biomarkers Prev10243248PubMed
5.
go back to reference Byrne, C, Colditz, GA, Willett, WC, Speizer, FE, Pollak, M, Hankinson, SE 2000Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic densityCancer Res6037443748PubMed Byrne, C, Colditz, GA, Willett, WC, Speizer, FE, Pollak, M, Hankinson, SE 2000Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic densityCancer Res6037443748PubMed
6.
go back to reference Boyd, NF, Stone, J, Martin, LJ, Jong, R, Fishell, E, Yaffe, M, et al. 2002The association of breast mitogens with mammographic densitiesBr J Cancer87876882PubMedCrossRef Boyd, NF, Stone, J, Martin, LJ, Jong, R, Fishell, E, Yaffe, M,  et al. 2002The association of breast mitogens with mammographic densitiesBr J Cancer87876882PubMedCrossRef
7.
go back to reference Alowami, S, Troup, S, Al-Haddad, S, Kirkpatrick, I, Watson, PH 2003Mammographic density is related to stroma and stromal proteoglycan expressionBreast Cancer Res5R129R135PubMedCrossRef Alowami, S, Troup, S, Al-Haddad, S, Kirkpatrick, I, Watson, PH 2003Mammographic density is related to stroma and stromal proteoglycan expressionBreast Cancer Res5R129R135PubMedCrossRef
8.
go back to reference Harvey, JA, Bovbjerg, VE 2004Quantitative assessment of mammographic breast density: relationship with breast cancer riskRadiology2302941PubMed Harvey, JA, Bovbjerg, VE 2004Quantitative assessment of mammographic breast density: relationship with breast cancer riskRadiology2302941PubMed
9.
go back to reference Vachon, CM, Kuni, CC, Anderson, K, Anderson, VE, Sellers, TA 2000Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States)Cancer Causes Control11653662PubMedCrossRef Vachon, CM, Kuni, CC, Anderson, K, Anderson, VE, Sellers, TA 2000Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States)Cancer Causes Control11653662PubMedCrossRef
10.
go back to reference Knight, JA, Martin, LJ, Greenberg, CV, Lockwood, GA, Byng, JW, Yaffe, MJ, et al. 1999Macronutrient intake and change in mammographic density at menopause: results from a randomized trialCancer Epidemiol Biomarkers Prev8123128PubMed Knight, JA, Martin, LJ, Greenberg, CV, Lockwood, GA, Byng, JW, Yaffe, MJ,  et al. 1999Macronutrient intake and change in mammographic density at menopause: results from a randomized trialCancer Epidemiol Biomarkers Prev8123128PubMed
11.
go back to reference Brisson, J, Verreault, R, Morrison, AS, Tennina, S, Meyer, F 1989Diet, mammographic features of breast tissue, and breast cancer riskAm J Epidemiol1301424PubMed Brisson, J, Verreault, R, Morrison, AS, Tennina, S, Meyer, F 1989Diet, mammographic features of breast tissue, and breast cancer riskAm J Epidemiol1301424PubMed
12.
go back to reference Rutter, CM, Mandelson, MT, Laya, MB, Seger, DJ, Taplin, S 2001Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapyJAMA285171176PubMedCrossRef Rutter, CM, Mandelson, MT, Laya, MB, Seger, DJ, Taplin, S 2001Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapyJAMA285171176PubMedCrossRef
13.
go back to reference Lam, PB, Vacek, PM, Geller, BM, Muss, HB 2000The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in VermontCancer89369375PubMedCrossRef Lam, PB, Vacek, PM, Geller, BM, Muss, HB 2000The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in VermontCancer89369375PubMedCrossRef
14.
go back to reference Haiman, CA, Bernstein, L, Berg, D, Ingles, SA, Salane, M, Ursin, G 2002Genetic determinants of mammographic densityBreast Cancer Res4R5PubMedCrossRef Haiman, CA, Bernstein, L, Berg, D, Ingles, SA, Salane, M, Ursin, G 2002Genetic determinants of mammographic densityBreast Cancer Res4R5PubMedCrossRef
15.
go back to reference Maskarinec, G, Lurie, G, Williams, AE, Le Marchand, L 2004An investigation of mammographic density and gene variants in healthy womenInt J Cancer112683688PubMedCrossRef Maskarinec, G, Lurie, G, Williams, AE, Le Marchand, L 2004An investigation of mammographic density and gene variants in healthy womenInt J Cancer112683688PubMedCrossRef
16.
go back to reference Hong, CC, Thompson, HJ, Jiang, C, Hammond, GL, Tritchler, D, Yaffe, M, et al. 2003Val158Met polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancerCancer Epidemiol Biomarkers Prev12838847PubMed Hong, CC, Thompson, HJ, Jiang, C, Hammond, GL, Tritchler, D, Yaffe, M,  et al. 2003Val158Met polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancerCancer Epidemiol Biomarkers Prev12838847PubMed
17.
go back to reference Dunning, AM, Healey, CS, Pharoah, PD, Teare, MD, Ponder, BA, Easton, DF 1999A systematic review of genetic polymorphisms and breast cancer riskCancer Epidemiol Biomarkers Prev8843854PubMed Dunning, AM, Healey, CS, Pharoah, PD, Teare, MD, Ponder, BA, Easton, DF 1999A systematic review of genetic polymorphisms and breast cancer riskCancer Epidemiol Biomarkers Prev8843854PubMed
18.
go back to reference Ziv, E, Shepherd, J, Smith-Bindman, R, Kerlikowske, K 2003Mammographic breast density and family history of breast cancerJ Natl Cancer Inst95556558PubMedCrossRef Ziv, E, Shepherd, J, Smith-Bindman, R, Kerlikowske, K 2003Mammographic breast density and family history of breast cancerJ Natl Cancer Inst95556558PubMedCrossRef
19.
go back to reference Taplin, SH, Thompson, RS, Schnitzer, F, Anderman, C, Immanuel, V 1990Revisions in the risk-based Breast Cancer Screening Program at Group Health CooperativeCancer66812818PubMed Taplin, SH, Thompson, RS, Schnitzer, F, Anderman, C, Immanuel, V 1990Revisions in the risk-based Breast Cancer Screening Program at Group Health CooperativeCancer66812818PubMed
20.
go back to reference Taplin, SH, Mandelson, MT, Anderman, C, White, E, Thompson, RS, Timlin, D, et al. 1997Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a populationCancer Epidemiol Biomarkers Prev6625631PubMed Taplin, SH, Mandelson, MT, Anderman, C, White, E, Thompson, RS, Timlin, D,  et al. 1997Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a populationCancer Epidemiol Biomarkers Prev6625631PubMed
21.
go back to reference Taplin, SH, Ichikawa, L, Buist, DS, Seger, D, White, E 2004Evaluating organized breast cancer screening implementation: the prevention of late-stage disease?Cancer Epidemiol Biomarkers Prev13225234PubMedCrossRef Taplin, SH, Ichikawa, L, Buist, DS, Seger, D, White, E 2004Evaluating organized breast cancer screening implementation: the prevention of late-stage disease?Cancer Epidemiol Biomarkers Prev13225234PubMedCrossRef
22.
go back to reference Bassett, LW, Feig, SA, Jackson, VP, Kopans, DB, Linver, MN, Sickles, EA, et al. 1998American college of radiology (ACR) breast imaging reporting and data system (BI-RADS™)3American College of RadiologyReston (VA) Bassett, LW, Feig, SA, Jackson, VP, Kopans, DB, Linver, MN, Sickles, EA,  et al. 1998American college of radiology (ACR) breast imaging reporting and data system (BI-RADS™)3American College of RadiologyReston (VA)
23.
go back to reference Boyd, NF, Dite, GS, Stone, J, Gunasekara, A, English, DR, McCredie, MR, et al. 2002Heritability of mammographic density, a risk factor for breast cancerN Engl J Med347886894PubMedCrossRef Boyd, NF, Dite, GS, Stone, J, Gunasekara, A, English, DR, McCredie, MR,  et al. 2002Heritability of mammographic density, a risk factor for breast cancerN Engl J Med347886894PubMedCrossRef
24.
go back to reference Hong, CC, Tang, BK, Rao, V, Agarwal, S, Martin, L, Tritchler, D, et al. 2004Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional studyBreast Cancer Res6R338R351PubMedCrossRef Hong, CC, Tang, BK, Rao, V, Agarwal, S, Martin, L, Tritchler, D,  et al. 2004Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional studyBreast Cancer Res6R338R351PubMedCrossRef
25.
go back to reference Haiman, CA, Hankinson, SE, Vivo, I, Guillemette, C, Ishibe, N, Hunter, DJ, et al. 2003Polymorphisms in steroid hormone pathway genes and mammographic densityBreast Cancer Res Treat772736PubMedCrossRef Haiman, CA, Hankinson, SE, Vivo, I, Guillemette, C, Ishibe, N, Hunter, DJ,  et al. 2003Polymorphisms in steroid hormone pathway genes and mammographic densityBreast Cancer Res Treat772736PubMedCrossRef
26.
go back to reference Berg, WA, Campassi, C, Langenberg, P, Sexton, MJ 2000Breast imaging reporting and data system: inter- and intraobserver variability in feature analysis and final assessmentAJR Am J Roentgenol17417691777PubMed Berg, WA, Campassi, C, Langenberg, P, Sexton, MJ 2000Breast imaging reporting and data system: inter- and intraobserver variability in feature analysis and final assessmentAJR Am J Roentgenol17417691777PubMed
27.
go back to reference Byng, JW, Yaffe, MJ, Jong, RA, Shumak, RS, Lockwood, GA, Tritchler, DL, et al. 1998Analysis of mammographic density and breast cancer risk from digitized mammogramsRadiographics1815871588PubMed Byng, JW, Yaffe, MJ, Jong, RA, Shumak, RS, Lockwood, GA, Tritchler, DL,  et al. 1998Analysis of mammographic density and breast cancer risk from digitized mammogramsRadiographics1815871588PubMed
28.
go back to reference El-Bastawissi, AY, White, E, Mandelson, MT, Taplin, S 2001Variation in mammographic breast density by raceAnn Epidemiol11257263PubMedCrossRef El-Bastawissi, AY, White, E, Mandelson, MT, Taplin, S 2001Variation in mammographic breast density by raceAnn Epidemiol11257263PubMedCrossRef
29.
go back to reference Hall, IJ, Burke, W, Coughlin, S, Lee, NC 2001Population-based estimates of the prevalence of family history of cancer among womenCommunity Genet4134142PubMedCrossRef Hall, IJ, Burke, W, Coughlin, S, Lee, NC 2001Population-based estimates of the prevalence of family history of cancer among womenCommunity Genet4134142PubMedCrossRef
30.
go back to reference Hughes, KS, Roche, C, Campbell, CT, Siegel, N, Salisbury, L, Chekos, A, et al. 2003Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaireBreast J91925PubMedCrossRef Hughes, KS, Roche, C, Campbell, CT, Siegel, N, Salisbury, L, Chekos, A,  et al. 2003Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaireBreast J91925PubMedCrossRef
Metadata
Title
Varying Levels of Family History of Breast Cancer in Relation to Mammographic Breast Density (United States)
Authors
Anthony B. Crest
Erin J. Aiello
Melissa L. Anderson
Diana S. M. Buist
Publication date
01-08-2006
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 6/2006
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-0026-6

Other articles of this Issue 6/2006

Cancer Causes & Control 6/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine